Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTCN.L Regulatory News (TCN)

  • There is currently no data for TCN

Post-Period End Update

16 Nov 2020 07:00

RNS Number : 3483F
Tricorn Group PLC
16 November 2020
 

 

16 November 2020

Tricorn Group plc

("Tricorn", the "Company" or the "Group")

Post-Period End Update

Further to its announcement on 2 April 2020 advising of a change in its Accounting Reference Date from 31 March to 30 September and its announcement on 23 June 2020 of its unaudited interim results for the 6 months ended 31 March 2020, Tricorn Group plc (AIM: TCN.L), the AIM listed tube manipulation specialist, provides the following update.

Following the appointment of Michael Stock as Group Finance Director, who joined the Group on 3 August 2020 and the hiring of a new finance team, an internal review of the performance of the Group was conducted and various matters have come to light in the preparation of the Group's financial statements for the 18 month period ended 30 September 2020. At this stage, a balance sheet exposure risk estimated at approximately £3.6m has been identified. The £3.6m balance sheet exposure risk excludes an inter-company imbalance of approximately £1.0m which is still being investigated.

Approximately £1.1m of the exposure risk relates to the Group's US operation. This includes the write-off of capitalised development costs of £0.3m following a contract loss since the onset of COVID-19, the write-down of net inventory of £0.5m and a more prudent view on debtor recovery of £0.3m.

In the UK, adjustments are estimated at a further £2.5m. This relates to a stock write-down of £0.7m, approximately £0.6m relating to an audit of fixed assets combined with a change in accounting policies and £0.2m attributable to assumed non-recovery of debtor balances. The balance of approximately £1.0m is still under investigation.

The Group continues to work closely with BDO, the Group's new auditors, who were appointed subsequent to its audited Financial Statements for the year ended 31 March 2019. Further announcements will be made as appropriate and/or further information becomes available. 

Trading has been extremely challenging over the last 9 months and whilst the outlook still remains uncertain, demand levels from a number of customers is increasing and providing additional availability in the UK from the Group's invoice discounting facility. Of a total invoice discounting facility of £3.0m, as at 13 November 2020, the Group generated funding availability of approximately £1.8m (advanced at 90%) and has been fully drawn. Cash balances for the Group as at 13 November 2020 were approximately £0.7m.

 

For further information please contact:

 

Tricorn Group plc www.tricorn.uk.com

Andrew Moss, Chairman Tel +44 (0)7768 306 701

Mike Welburn, Chief Executive Tel +44 (0)7766 252 032

Michael Stock, Group Finance Director Tel +44 (0)7894 784 106

 

Shore Capital Tel +44 (0)20 7408 4080

Tom Griffiths

David Coaten

Henry Willcocks

 

Notes to Editors:

Tricorn is a value-added manufacturer and specialist manipulator of pipe and tubing assemblies to niche markets worldwide.

Headquartered in Malvern, UK, Tricorn employs around 300 employees and has five manufacturing facilities in China, USA and UK.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEELFFBFLZFBQ
Date   Source Headline
2nd Apr 20097:00 amRNSBoard Change
1st Apr 20093:47 pmRNSHolding(s) in Company
31st Mar 20097:00 amRNSDirector Dealing
2nd Mar 20094:33 pmRNSHolding(s) in Company
2nd Mar 20093:10 pmRNSHolding(s) in Company
26th Feb 200911:13 amRNSBoard Appointment
19th Feb 200912:13 pmRNSHolding(s) in Company
13th Feb 20091:43 pmRNSHolding(s) in Company
11th Feb 200911:49 amRNSHolding(s) in Company
6th Feb 200910:22 amRNSTrading Update
12th Dec 20087:00 amRNSInterim Results
17th Oct 20087:00 amRNSTrading Statement
18th Sep 20084:37 pmRNSAGM Statement
30th Jun 20083:22 pmRNSHolding(s) in Company
17th Jun 200812:25 pmRNSHolding(s) in Company
17th Jun 20087:00 amRNSPreliminary Results
8th Apr 20087:00 amRNSTrading Update
2nd Apr 20085:38 pmRNSHolding(s) in Company
2nd Apr 20085:33 pmRNSTotal Voting Rights
7th Mar 20087:00 amRNSAdditional Listing
20th Feb 20083:46 pmRNSHolding(s) in Company
15th Feb 20083:01 pmRNSHolding(s) in Company
7th Feb 200811:35 amRNSHolding(s) in Company
1st Feb 200810:29 amRNSAdditional Listing
31st Jan 20081:54 pmRNSHolding(s) in Company
13th Dec 20077:00 amRNSInterim Results
12th Nov 200711:08 amRNSChief Executive
25th Oct 20071:17 pmRNSRe Chief Executive
17th Oct 20071:31 pmRNSHolding(s) in Company
20th Sep 20073:17 pmRNSAGM Statement
3rd Sep 20073:16 pmRNSStatement re Chief Executive
17th Aug 200711:55 amRNSAIM Rule 26
2nd Jul 20073:51 pmRNSHolding(s) in Company
26th Jun 20077:02 amRNSAcquisition
26th Jun 20077:02 amRNSPreliminary Results
21st Mar 20073:26 pmRNSHolding(s) in Company
19th Feb 20071:20 pmRNSHolding(s) in Company
22nd Dec 200612:51 pmRNSTotal Voting Rights
18th Dec 20065:52 pmRNSHolding(s) in Company
14th Dec 20067:01 amRNSInterim Results
10th Oct 20062:50 pmRNSHolding(s) in Company
14th Sep 200610:51 amRNSAGM Statement
13th Jun 20063:06 pmRNSAcquisition
6th Jun 20069:12 amRNSAcquisition
6th Jun 20069:12 amRNSPreliminary Results
1st Dec 20057:30 amRNSInterim Results
20th Oct 20052:42 pmRNSSchedule 10
6th Sep 200512:32 pmRNSAGM Statement
6th Sep 200512:15 pmRNSAGM Statement
16th Jun 20053:00 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.